checkAd

     217  0 Kommentare Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting - Seite 3

    Contact:

    Kim Fox, Vice President, Communications, kfox@milestonepharma.com

    Investor Relations

    Chris Calabrese, ccalabrese@lifesciadvisors.com

    Lesen Sie auch

    Kevin Gardner, kgardner@lifesciadvisors.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting - Seite 3 Data from this large safety-trial also published in The Journal of the American College of CardiologyMONTREAL and CHARLOTTE, N.C., April 08, 2024 (GLOBE NEWSWIRE) - Milestone Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused …